InvestorsHub Logo
Followers 28
Posts 1440
Boards Moderated 0
Alias Born 12/18/2014

Re: ATLnsider post# 607355

Thursday, 07/06/2023 8:51:58 PM

Thursday, July 06, 2023 8:51:58 PM

Post# of 693664
ATLn, I’ll chime in with $.02 starting with old post where the highlighted section may align with your thinking.

Know-Fear
Re: flipper44 post# 558564
Wednesday, January 11, 2023 1:16:04 PM
Post# of 607373
Agreed, sometimes my sarcasm doesn’t translate well on the message board. Hopefully, and to quote another poster this is potentially “next level stuff”, perhaps along the lines of what I was alluding to in post 547857.
A couple other quick thoughts as I don’t have much time. The Flaskworks patents* provide more protection IMO than the patent they got on Direct back in October 2021. That stated I sense that using L would be the preferred method in practice medically. As removing as much tumor burden as possible as well as ensuring a greater antigen uptake will provide better efficacy. And any synergies with CI’s will be at dose levels more tolerable.

* Suspect some of the Flaskworks patents are defensive in nature to block alternate paths.



Agree likely some “art” involved in administering Direct injections to attain/ensure efficacy.
Also on the direct patent the prosecution was lengthy. The time and changes made some think the claims were diminished. I think the attained what they needed (ex an I made this points at the time)

Coming in for landing try add more when time permits

Recovering former moderator.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News